From Health Affairs Today <[email protected]>
Subject What MFN Drug Pricing Could Mean for the U.S.
Date April 14, 2026 8:03 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
JOIN US: Understanding ICHRA With Jason Levitis

View in browser ([link removed] )

LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

X ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

Dear John,

Join us on April 30 for a free virtual event exploring how provider prices affect commercial health care spending; the key factors that drive rising hospital prices; and how stakeholders are translating evidence into policy and market interventions.

Join Us
([link removed] )

Today's Featured Articles

A Vision For MIPS’s Next 10 Years: Short-Term Changes, Long-Term Strategy Development ([link removed] )

Michelle Schreiber and Dora Lynn Hughes

Inflation Reduction Act Changes To Part D Plan Design: Lower Premiums, Higher Deductibles, And Some Smaller Formularies ([link removed] )

David M. Anderson et al.

part of our Eye On The IRA series

More from Eye On The IRA series

Trends In Biopharmaceutical Clinical Trials After Medicare Drug Price Negotiation ([link removed] )

So-Yeon Kang et al. (January 2026)

Medicare Part D Redesign Savings May Be Lower For Beneficiaries With Spending Below The Out-Of-Pocket Cap ([link removed] )

Stacie B. Dusetzina et al. (June 2025)

The AI Wild West Is Over: Why 2026 Is the Year Health Systems Must Take Control ([link removed] )

Premier

Sponsored by Premier ([link removed] )

What Most Favored Nation Drug Pricing Would Mean for the US ([link removed] )

Health Affairs' Rob Lott interviews James Robinson of the University of California Berkeley about his recent paper exploring most favored nation drug pricing, weighing its feasibility, likely effects on drug launch prices, and implications for global pharmaceutical innovation and investment.

Listen
([link removed] )

Understanding ICHRA With Jason Levitis ([link removed] )

Join Health Affairs Publishing on May 13 for an exclusive Insider virtual event exploring individual coverage health reimbursement arrangements (ICHRAs) with Urban Institute’s Jason Levitis.

Save Your Spot
([link removed] )

health-affairs-45-04-order-issue_eNewsletter-banner ([link removed] )

About Health Affairs Publishing

Health Affairs Publishing ([link removed] ) delivers rigorous, nonpartisan research and analysis to improve health and health care. For over 40 years, we’ve turned complex health policy research into clear insights that guide decision makers toward effective solutions.

Sign up for all of our newsletters. ([link removed] )

Copyright © Health Affairs Publishing, LLC

Privacy Policy ([link removed] )

Health Affairs Publishing, 1101 Connecticut Avenue, NW, Suite 500, Washington, DC 20036, United States, 202-408-6801

Manage preferences ([link removed] )
Screenshot of the email generated on import

Message Analysis